Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?

Table 4

Baseline characteristics of our SCA patients versus VerifyNow test results.

	Nonresistant%	Resistant%	value
Age	56.9 ± 8.48	62 ± 8.02	0.9
Sex			0.41
Male	58.3%	20%
Female	41.7%	80%
SCA type			0.2
ST (+)	36%	60%
ST (−)	64%	40%
Familial ACD			0.8
Presence	2.8%	0%
Absence	97.2%	100%
Personal ACD			0.3
Presence	41.7%	20%
Absence	58.3%	80%
Diabetes			0.6
Presence	40.3%	40%
Absence	59.7%	60%
HTA			0.46
Presence	47.2%	60%
Absence	52.8%	40%
Dyslipidemia			0.22
Presence	16.7%	40%
Absence	83.3%	60%
Smoking			0.6
Presence	40.3%	40%
Absence	59.7%	60%
Creatinine (mg/L)	11.6 ± 10.87	15 ± 4.34
Fibrinogen	3.57 ± 1.06	5.03 ± 1.14
Pq	242333 ± 102412	159427 ± 79609
IPP
Used	50.38%	60%
Nonused	49.62%	40%

Statistically significant.